MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Thermo Fisher Gets into Companion Diagnostic Collaboration with Janssen
Image by Geralt on Pixabay

Thermo Fisher Gets into Companion Diagnostic Collaboration with Janssen

The Waltham, MA-based company said both firms will work together to validate multiple biomarkers with the Oncomine Dx Target Test, which will be used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer.

Thermo Fisher Scientific has signed an agreement with Janssen Biotech to co-develop a companion diagnostic in the oncology space. Janssen Biotech is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

The pact calls for both firms to work together to validate multiple biomarkers for use with Waltham, MA-based Thermo Fisher’s Oncomine Dx Target Test, which will be used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer. Right now, the Oncomine assay contains 46 cancer-related biomarkers.

"The ability of the Oncomine Dx Target Test to rapidly detect variants of interest from very small quantities of DNA or RNA samples makes this technology ideally suited to support development programs requiring an NGS-based workflow that delivers actionable insights consistently," Peter Silvester, senior vice president and president of Life Sciences Solutions at Thermo Fisher Scientific, said in a release. "We are confident that this approach to patient stratification helps expedite drug development initiatives which ultimately are designed to promote better health outcomes through targeted therapies."

Thermo Fisher’s collaboration comes at a time when the company is in the middle of acquiring Qiagen for $11.5 billion. News of the acquisition follows months of rumors that Thermo Fisher would make a move to pick up Venlo, Netherlands-based Qiagen.

TAGS: News
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish